Recruiting nowPhase 2
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
Updated 2026-03-19 · NCT07227948See eligibility →
Sponsor
Active studies whose public registry record names The University of Texas Health Science Center, Houston as lead sponsor.
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.